Skip to main content

MedCloud Minute

The MedCloud Minute blog is researched, fact-checked, edited and updated by the editors of MedCloudInsider.com, with writing assistance from AI. To submit your company's press release for consideration, contact [email protected].


MedCloud Minute


MethodSense Adds AI Compliance Platform for Medtech Companies

Key Takeaways

  • MethodSense launches LuminLogic NextGen to bring AI-powered regulatory and quality compliance workflows to medical technology companies.
  • LuminLogic NextGen supports regulatory strategy, risk assessment, documentation, quality management, and medical device product lifecycle activities.
  • Human-in-the-loop AI keeps regulatory professionals responsible for consequential compliance decisions while improving traceability and workflow support.

More

Posted by MedCloudInsider Editors on 09/16/20260 comments


Share

Subsalt Adds Secure Runtime for Analyzing Protected Health Data

Key Takeaways

  • Subsalt Secure Runtime enables privacy-preserving health data analytics without exposing patient-level protected health information.
  • Health systems control data access, permitted analyses, and exportable outputs while users run Python-based analytics.
  • Subsalt MCP connects AI applications to de-identified healthcare datasets while preserving existing access and governance controls.

Subsalt, a provider of privacy-preserving health data infrastructure, has launched Secure Runtime, a computing environment designed to let health systems analyze protected health information without exposing patient-level data to users.


More

Posted by MedCloudInsider Editors on 09/16/20260 comments


Share

GrayMatters Health Applies Machine Learning to Digital Biomarkers for Psychiatry

Key Takeaways

  • GrayMatters Health uses machine learning to develop digital brain biomarkers for PTSD and depression treatment.
  • Prism combines EEG-based biomarkers with interactive simulations that help patients regulate condition-related brain activity.
  • FDA-cleared Prism demonstrates how AI-powered neurological measurements can supplement traditional psychiatric care and clinical monitoring.

GrayMatters Health, a mental health technology company developing digital biomarker-based treatments, is highlighting its use of machine learning to develop digital brain biomarkers intended to supplement the symptom reporting and clinical observation traditionally used in psychiatric care.


More

Posted by MedCloudInsider Editors on 09/15/20260 comments


Share

Egnite Updates CardioCare UI to Consolidate Cardiovascular Patient Data

Key Takeaways

  • Egnite redesigns CardioCare to help cardiovascular teams review, prioritize and manage patients with untreated heart disease.
  • CardioCare combines EMR, echocardiogram, ECG, lab, referral and encounter data into pathology-focused patient views.
  • AI-powered cardiovascular intelligence surfaces clinical events and prioritizes patients using American Heart Association and ACC guidelines.

Egnite, a healthcare AI company focused on helping clinicians identify and manage patients with untreated heart disease, has updated its CardioCare cardiovascular intelligence platform with a redesigned interface intended to make patient information easier for clinical teams to review and prioritize. CardioCare is used by more than 80 structural heart and cardiovascular programs nationwide.


More

Posted by MedCloudInsider Editors on 09/09/20260 comments


Share

Memorial Hermann Uses Epic AI to Draft Patient Test Result Messages

Key Takeaways

  • Memorial Hermann uses Epic’s Art AI assistant to generate patient-friendly explanations of laboratory and imaging results.
  • Art-generated messages reduced patient follow-up questions by 32 percent while saving clinicians time on result comments.
  • Epic Art keeps clinicians responsible for reviewing and personalizing AI-generated communications before messages reach patients.

Memorial Hermann Health System, a nonprofit health care system, is using an AI feature built into Epic to help clinicians explain test results to patients. The health system began piloting the technology in December 2025 and has since expanded it across the organization.


More

Posted by MedCloudInsider Editors on 09/09/20260 comments


Share

Unchained Labs Combines AI and Automation for Biologics Screening

Key Takeaways

  • Unchained Labs launches AI Developability Workcell to automate biologic drug candidate screening and analytical workflows.
  • Stuntman integrates Stunner, Aunty, and Lil’ Tuna data, using AI to compare biologic candidates automatically.
  • Automated developability screening reduces manual sample handling while increasing candidate throughput and maintaining connected analytical datasets.

Unchained Labs, a provider of AI-driven automation and analytical tools for life sciences research, has launched its AI Developability Workcell, a laboratory system designed to automate the process of screening biologic drug candidates for characteristics that can affect their suitability for further development.


More

Posted by MedCloudInsider Editors on 09/09/20260 comments


Share

DarwinHealth Applies AI to Map Drug-Resistant Cancer Cell States

Key Takeaways

  • DarwinHealth introduces Quantum Cancer Biology, combining AI and systems biology for cell-state-based precision oncology.
  • VIPER technology identifies Master Regulator proteins across malignant cell states to uncover potential therapeutic vulnerabilities.
  • AI-driven drug combination analysis targets multiple cancer cell populations to address treatment resistance in difficult malignancies.

DarwinHealth, an AI-centric biotechnology company, has introduced Quantum Cancer Biology, a precision oncology framework that uses AI and systems biology to analyze multiple malignant cell states within individual tumors rather than focusing primarily on genetic mutations.


More

Posted by MedCloudInsider Editors on 08/31/20260 comments


Share

Monod Bio Licenses AI-Designed Proteins for Drug Discovery Assays

Key Takeaways

  • Monod Bio licenses AI-designed LuxSit and NovoBodies protein technologies to SignalChem Biotech for drug discovery research.
  • SignalChem can use Monod Bio technologies in custom luminescent assays and protein-fusion services for research customers.
  • AI-powered de novo protein design expands into CRO services through SignalChem and Sino Biological’s global life sciences network.

Monod Bio, a Seattle-based AI-enabled protein design company, has licensed two of its AI-designed protein technologies to SignalChem Biotech, a subsidiary of Sino Biological, for use in custom drug discovery and life sciences research services. The nonexclusive agreement covers Monod Bio’s LuxSit de novo luciferase technology and NovoBodies.


More

Posted by MedCloudInsider Editors on 08/31/20260 comments


Share

Precision BioLogic Expands Hemostasis Diagnostics Through Acquisitions

Key Takeaways

  • Precision BioLogic expands hemostasis diagnostics by combining capabilities from Affinity Biologicals and George King Bio-Medical.
  • CRYOcheck Chromogenic Factor VIII assay supports accurate hemophilia testing as newer therapies including Mim8 emerge.
  • ISTH 2026 research explored anticoagulant-resistant lupus anticoagulant testing and factor VIII therapy effects on inhibitor assays.

Precision BioLogic, a developer of hemostasis diagnostic products, is expanding its hemostasis diagnostics and research business by combining capabilities from two acquired subsidiaries, Affinity Biologicals and George King Bio-Medical.


More

Posted by MedCloudInsider Editors on 08/31/20260 comments


Share

HearingLife Introduces Oticon Reveal Hearing Aid with Dual AI Processing

Key Takeaways

  • HearingLife offers Oticon Reveal hearing aids with Dual AI technology for simultaneous speech and environmental sound processing.
  • Oticon Reveal uses BrainHearing methodology to preserve speech clarity while maintaining broader environmental sound context.
  • Rechargeable Oticon Reveal supports audio streaming and Oticon CROS technology for people with single-sided hearing loss.

HearingLife, a hearing care company, has begun offering Oticon Reveal, a hearing aid that uses what the company describes as Dual AI technology to process speech and environmental sounds simultaneously.


More

Posted by MedCloudInsider Editors on 08/25/20260 comments


Share

Oracle Health Expands Clinical AI Agent with Coding and Chart Review

Key Takeaways

  • Oracle Health expands Clinical AI Agent with automated medical coding, voice dictation, and AI-powered patient chart review.
  • Oracle’s AI agents use semantic reasoning and shared clinical context to automate documentation workflows while maintaining clinician control.
  • AI-generated medical coding could reduce manual work but requires human review, auditability, compliance, and patient data protection.

Oracle Health, a provider of health care technology and clinical software, has expanded its Clinical AI Agent with capabilities for automated coding, dictation and chart review, broadening the system beyond its existing clinical documentation functions.


More

Posted by MedCloudInsider Editors on 08/25/20260 comments


Share

Insilico Medicine Adds Biological Age to Virtual Cell Modeling

Key Takeaways

  • Insilico Medicine adds biological age to virtual cell models for AI-powered aging and disease research.
  • Multi-agent AI platform coordinates biological data and computational workflows to generate virtual aging cell models.
  • Virtual Aging Cell technology could support age-related disease research, though computational predictions still require experimental validation.

Insilico Medicine, a clinical-stage drug discovery company powered by generative artificial intelligence (AI), has introduced biological age into its virtual cell research and previewed a multi-agent AI platform for generating virtual aging cells, extending its use of artificial intelligence for modeling human biology.


More

Posted by MedCloudInsider Editors on 08/18/20260 comments


Share